Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Hepatitis C

  Free Subscription

Articles published in Am J Gastroenterol

Retrieve available abstracts of 20 articles:
HTML format

Single Articles

    November 2022
  1. KRAMER JR, Cao Y, Li L, Smith D, et al
    Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
    Am J Gastroenterol. 2022;117:1834-1844.
    PubMed     Abstract available

    Continuing Medical Education Questions: November 2022.
    Am J Gastroenterol. 2022;117:1742.
    PubMed     Abstract available

    September 2022
  3. VELOZ MFG, Han K, Oakes K, Robertson D, et al
    Results of a model of delivering hepatitis C care in a homeless metropolitan population in England.
    Am J Gastroenterol. 2022 Sep 30. pii: 00000434-990000000-00534.
    PubMed     Abstract available

    June 2022
  4. INNES H, Hamill V, McDonald SA, Hayes PC, et al
    Comparing predicted probability of hepatocellular carcinoma in cirrhosis patients to the general population: an opportunity to improve risk communication?
    Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00428.
    PubMed     Abstract available

  5. CALVARUSO V, Celsam C, D'Ambrosio R, Simone F, et al
    RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00413.
    PubMed     Abstract available

    May 2022
  6. AMPUERO J, Carmona I, Sousa F, Rosales JM, et al
    Correction to: A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure.
    Am J Gastroenterol. 2022;117:819.

    January 2022
  7. FAYED A, Hegazy MT, Biard L, Vieira M, et al
    Relapse of HCV-Cryoglobulinemic Vasculitis Following Sustained Viral Response after Interferon-free Direct-Acting Antivirals.
    Am J Gastroenterol. 2022 Jan 29. pii: 00000434-990000000-00234.
    PubMed     Abstract available

    October 2021
  8. LI J, Le MH, Barakat MT, Cheung RC, et al
    The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016.
    Am J Gastroenterol. 2021;116:2068-2078.
    PubMed     Abstract available

    September 2021
  9. AMPUERO J, Carmona I, Sousa F, Rosales JM, et al
    A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure.
    Am J Gastroenterol. 2021 Sep 9. pii: 00000434-900000000-98663.
    PubMed     Abstract available

  10. CHUANG WL, Hu TH, Buggisch P, Moreno C, et al
    Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease.
    Am J Gastroenterol. 2021;116:1924-1928.
    PubMed     Abstract available

  11. ZAMOR PJ, Brown A, Dylla DE, Dillon JF, et al
    High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.
    Am J Gastroenterol. 2021;116:1896-1904.
    PubMed     Abstract available

    August 2021
  12. KONSTANTELOS N, Shakeri A, McCormack D, Feld JJ, et al
    Impact of COVID-19 on Prescribing Trends of Direct-Acting Antivirals for the Treatment of Hepatitis C in Ontario, Canada.
    Am J Gastroenterol. 2021;116:1738-1740.
    PubMed     Abstract available

    June 2021
  13. RINALDI L, Messina V, Di Marco V, Iovinella V, et al
    Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience.
    Am J Gastroenterol. 2021;116:1248-1255.
    PubMed     Abstract available

    April 2021
  14. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.

    March 2021
  15. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    PubMed     Abstract available

    February 2021
  16. TOSETTI G, Degasperi E, Farina E, D'Ambrosio R, et al
    Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Beta-Blocker Therapy.
    Am J Gastroenterol. 2021 Feb 18. pii: 00000434-900000000-98881.
    PubMed     Abstract available

    December 2020
  17. LI J, Gordon SC, Zhou Y, Boscarino JA, et al
    Sex Differences in Extrahepatic Outcomes After Antiviral Treatment for Hepatitis C.
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  18. DESAI N, Rich NE, Jain MK, Blackwell JM, et al
    Randomized Clinical Trial of Inreach With or Without Mailed Outreach to Promote Hepatitis C Screening in a Difficult-to-Reach Patient Population.
    Am J Gastroenterol. 2020;Publish Ahead of Print.
    PubMed     Abstract available

    October 2020
  19. SINN DH, Kang D, Guallar E, Chang Y, et al
    Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000966.
    PubMed     Abstract available

  20. SHARMA S, Agarwal S, Gunjan D, Kaushal K, et al
    Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
    Am J Gastroenterol. 2020;115:1650-1656.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.